Literature DB >> 1606547

DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group.

J M Truelson1, S G Fisher, T E Beals, K D McClatchey, G T Wolf.   

Abstract

BACKGROUND: Alterations in DNA content, nuclear morphologic characteristics, and histologic grading have been associated with prognosis in several types of solid malignant neoplasms.
METHODS: To determine the potential usefulness of these factors in predicting tumor behavior in patients with laryngeal squamous cell carcinoma, tumor specimens from 88 previously untreated patients with Stage III or IV cancers were studied. The DNA content and nuclear area (NA) were measured for individual nuclei of each tumor with the use of Azure A-stained frozen sections. An adjusted DNA index (aDI) for each patient was calculated from the slope of the linear regression analysis of nuclear DNA index on NA. Hematoxylin and eosinstained sections were examined and graded systematically for histologic growth pattern. All patients were enrolled in a prospective clinical trial and had laryngectomy and postoperative radiation therapy.
RESULTS: The disease-free survival length was longer and the relapse rates were lower in patients with a low aDI (P less than 0.005) and with tumors exhibiting low-grade growth patterns (P less than 0.001).
CONCLUSIONS: These parameters were independent of staging variables and were better predictors of tumor relapse than traditional clinical staging classifications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606547     DOI: 10.1002/1097-0142(19920701)70:1<56::aid-cncr2820700110>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Authors:  Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

2.  Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.

Authors:  Gregory T Wolf; William Winter; Emily Bellile; Ariane Nguyen; C R Donnelly; Jonathan B McHugh; Dafydd Thomas; Lahin Amlani; Laura Rozek; Yu L Lei
Journal:  Oral Oncol       Date:  2018-10-22       Impact factor: 5.337

3.  DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.

Authors:  J Cappiello; P Nicolai; A R Antonelli; F Facchetti; M Cadei; A Cornacchiari; P G Grigolato
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Morphometric Analysis of Suprabasal Cell Layer in Oral Epithelial Dysplasia: A Computer-assisted Microscopic Study.

Authors:  Viswanathan Prema; Thomson Thomas; Prasad Harikrishnan; Mani Viswanathan; Kenniyan Kumar Srichinthu; Krishnan Rajkumar
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

5.  Morphometry of the basal cell layer of oral leukoplakia and oral squamous cell carcinoma using computer-aided image analysis.

Authors:  T Smitha; P Sharada; Hc Girish
Journal:  J Oral Maxillofac Pathol       Date:  2011-01

6.  Nuclear features in oral squamous cell carcinoma: A computer-assisted microscopic study.

Authors:  D B Nandini; R V Subramanyam
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

7.  Nuclear features in different grades of epithelial dysplasia in leukoplakia: A computer assisted microscopic study.

Authors:  Mohsin Gadiwan; Gs Madhushankari; Dd Mandana; Sb Praveen; Ms Selvamani; Ds Pradeep
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

8.  Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  P Inki; H Joensuu; R Grénman; P Klemi; M Jalkanen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.